BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 22692579)

  • 1. Clinical significance of incidental colonic 18F-FDG uptake on PET/CT images in patients with gastric adenocarcinoma.
    Shim JH; O JH; Oh SI; Yoo HM; Jeon HM; Park CH; Kim SH; Song KY
    J Gastrointest Surg; 2012 Oct; 16(10):1847-53. PubMed ID: 22752472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krukenburg tumour: Role of 18F-FDG PET/CT in identifying the primary site.
    Usmani S; Murad S; Kandari FA; Maraghy MA
    J Pak Med Assoc; 2024 Mar; 74(3):597-598. PubMed ID: 38591310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer.
    Milardovic R; Beslic N; Sadija A; Ceric S; Bukvic M; Dzananovic L
    Acta Inform Med; 2020 Jun; 28(2):119-123. PubMed ID: 32742064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and clinical value of [18F]FDG PET/CT in the follow-up regimen in IIA-IIID stage cutaneous malignant melanoma after first regional recurrence.
    Dancheva Z; Konsoulova A; Dyankova M; Stoeva T; Chausheva S; Klisarova A
    Nucl Med Rev Cent East Eur; 2022 Dec; ():. PubMed ID: 36475312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of incidental bowel FDG uptake.
    Lee JC; Hartnett GF; Ravi Kumar AS
    J Gastrointest Surg; 2013 Dec; 17(12):2182. PubMed ID: 23784314
    [No Abstract]   [Full Text] [Related]  

  • 6. The Diagnostic Performance of 18F-FDG PET/CT in Recurrent Pancreatic Cancer: A Systematic Review and Meta-analysis.
    A G; Shan Y; Huo H; Ding C; Sun C
    Appl Bionics Biomech; 2022; 2022():3655225. PubMed ID: 35756868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-CT in the sub-arctic region of Norway 2010-2013. At the edge of what is possible?
    Norum J; Søndergaard U; Traasdahl E; Nieder C; Tollåli G; Andersen G; Sundset R
    BMC Med Imaging; 2015 Aug; 15():36. PubMed ID: 26316132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[18F]FDG-PET/CT in Cancer of Unknown Primary Tumor-A Retrospective Register-Based Cohort Study.
    Rimer H; Jensen MS; Dahlsgaard-Wallenius SE; Eckhoff L; Thye-Rønn P; Kristiansen C; Hildebrandt MG; Gerke O
    J Imaging; 2023 Aug; 9(9):. PubMed ID: 37754942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent non-rheumatic streptococcal myocarditis: 18F-FDG PET/CMR findings.
    Baltzinger P; El Ghannudi S; Germaini M; Von Hunolstein JJ; Zeyons F; Imperiale A
    QJM; 2024 Jan; ():. PubMed ID: 38273703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: The Diagnostic Performance of 18F-FDG PET/CT in Recurrent Pancreatic Cancer: A Systematic Review and Meta-analysis.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9769050. PubMed ID: 38152753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of F-18 FDG PET or PET/CT for detection of recurrent gastric cancer: a systematic review and meta-analysis.
    Choi CI; Park JK; Jeon TY; Kim DH
    J Yeungnam Med Sci; 2023 Nov; 40(Suppl):S37-S46. PubMed ID: 37587035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.
    Kim TH; Kim IH; Kang SJ; Choi M; Kim BH; Eom BW; Kim BJ; Min BH; Choi CI; Shin CM; Tae CH; Gong CS; Kim DJ; Cho AE; Gong EJ; Song GJ; Im HS; Ahn HS; Lim H; Kim HD; Kim JJ; Yu JI; Lee JW; Park JY; Kim JH; Song KD; Jung M; Jung MR; Son SY; Park SH; Kim SJ; Lee SH; Kim TY; Bae WK; Koom WS; Jee Y; Kim YM; Kwak Y; Park YS; Han HS; Nam SY; Kong SH;
    J Gastric Cancer; 2023 Jan; 23(1):3-106. PubMed ID: 36750993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of
    Zhang Z; Zheng B; Chen W; Xiong H; Jiang C
    Exp Ther Med; 2021 Feb; 21(2):164. PubMed ID: 33456531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up after curative resection for gastric cancer: Is it time to tailor it?
    Aurello P; Petrucciani N; Antolino L; Giulitti D; D'Angelo F; Ramacciato G
    World J Gastroenterol; 2017 May; 23(19):3379-3387. PubMed ID: 28596674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
    Sharma P; Singh H; Suman SK; Sharma A; Reddy RM; Thulkar S; Bal C; Malhotra A; Kumar R
    Nucl Med Commun; 2012 Sep; 33(9):960-6. PubMed ID: 22692579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
    Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
    Bilici A; Ustaalioglu BB; Seker M; Kefeli U; Canpolat N; Tekinsoy B; Ozugur S; Gumus M
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):64-73. PubMed ID: 20838995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
    Li P; Liu Q; Wang C; Wang T; Liu J; Huang G; Song S
    Ann Nucl Med; 2016 Apr; 30(3):179-87. PubMed ID: 26830546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.